Stocks and Investing Stocks and Investing
Fri, August 4, 2017
Thu, August 3, 2017
Wed, August 2, 2017
Tue, August 1, 2017
Mon, July 31, 2017
Fri, July 28, 2017
Thu, July 27, 2017
Wed, July 26, 2017

Matthew Harrison Maintained (BIIB) at Hold with Increased Target to $311 on, Jul 26th, 2017


Published on 2024-10-25 21:55:34 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $301 to $311 on, Jul 26th, 2017.

Matthew has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


This is the rating of the analyst that currently disagrees with Matthew


  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017